U.S. Food And Drug Administration

Latest Stories

Kansas lab built COVID-19 test used by colleges, Hollywood

By CELIA LLOPIS-JEPSEN - Associated Press

Pfizer signs are seen out front of the Pfizer Research &amp; Development Laboratories Wednesday, July 22, 2020, in Groton, Conn. Pfizer on Tuesday, July 28, reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)

Pfizer tops 3Q earnings views, makes progress on COVID shot

By LINDA A. JOHNSON - Associated Press

FILE - In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, Oct. 26, 2020, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to help. (David Morrison/Eli Lilly via AP, File)

Lilly antibody drug fails in a COVID-19 study; others go on

By MARILYNN MARCHIONE - Associated Press

FILE - In this April 2, 2020, photo taken through a tinted car window, a technician takes a nasal swab for a new coronavirus detection test at a drive-thru testing facility in Abu Dhabi, United Arab Emirates. U.S. diplomats and security officials privately warned the state of Nevada not to use Chinese-made coronavirus test kits donated by the United Arab Emirates over concerns about patient privacy, test accuracy and Chinese government involvement, documents obtained by The Associated Press show. (AP Photo/Jon Gambrell, File)

US warned Nevada not to use Chinese COVID tests from UAE

By JON GAMBRELL and MICHELLE L. PRICE - Associated Press

In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. (David Morrison/Eli Lilly via AP)

Possible safety issue spurs pause of COVID-19 antibody study

By Marilynn Marchione and Linda A. Johnson - Associated Press

President Donald Trump drives past supporters gathered outside Walter Reed National Military Medical Center in Bethesda, Md., Sunday, Oct. 4, 2020. Trump was admitted to the hospital after contracting COVID-19. (AP Photo/Anthony Peltier)

Study shows hydroxychloroquine benefits that would help Trump: author

By Rowan Scarborough - The Washington Times

FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Tuesday, Sept. 8, 2020, the top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus said that they will stick to the highest ethical and scientific standards in testing and manufacturing and will make the well-being of those getting vaccinated their top priority. (AP Photo/Hans Pennink)

Companies testing vaccines pledge safety, high standards

By LINDA A. JOHNSON - Associated Press

Arizona State shifts housing plans amid COVID-19 case rise

Associated Press

Illinois Editorial Roundup:

By The Associated Press - Associated Press

FILE - In this Friday, June 12, 2020 file photo, a doctor holds a bag of blood plasma donated by a COVID-19 survivor at at blood bank in La Paz, Bolivia. The U.S. Food and Drug Administration authorized the use of blood plasma for what's called “emergency use” during the coronavirus pandemic, but the World Health Organization (WHO) on Monday AUG. 24, 2020, cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy. (AP Photo/Juan Karita, FILE)

UN cautions that virus plasma treatment still experimental

By MARIA CHENG - Associated Press

This June 27, 2019, file photo President Donald Trump's Twitter feed is photographed on an Apple iPad in New York. (AP Photo/J. David Ake, File)

Trump tears into FDA, speculates ‘deep state’ delaying coronavirus vaccine until after election

By Andrew Blake - The Washington Times

FILE - This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Investors are driving shares of drug developer BioMarin down by a third after U.S. regulators rejected its potentially game-changing gene therapy for hemophilia A patients. The FDA's rejection late Tuesday, Aug. 18, 2020, means BioMarin will have to complete an ongoing late-stage patient study. (AP Photo/Jacquelyn Martin, File)

FDA blocks much-anticipated BioMarin hemophilia gene therapy

By LINDA A. JOHNSON - Associated Press

An outdoor canopy shields Shawn Grant, left, owner of District One Barbers West, as he gives a haircut to Thomas Duncan outside his shop, Tuesday, Aug. 18, 2020, in the Los Feliz section of Los Angeles. A heat wave continued to bring triple-digit temperatures to the Los Angeles area. (AP Photo/Chris Pizzello)

The Latest: South Korea has 3rd day of 200-plus new cases

By The Associated Press - Associated Press

Pritzker touts U of I saliva test as possible ‘game changer’

Associated Press

Federal agencies appeal suspension of abortion pill rule

By MICHAEL KUNZELMAN - Associated Press

President Donald Trump wears a face mask as he participates in a tour of Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)

Trump defends disproved COVID-19 treatment

By DARLENE SUPERVILLE and AMANDA SEITZ - Associated Press

In this May 4, 2020, file photo from the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. (University of Maryland School of Medicine via AP) ** FILE **

Feds partner with Pfizer to supply up to 600 million coronavirus vaccine doses

By David Sherfinski - The Washington Times

Expert warns it will be ‘challenging’ to keep low virus rate

By SUSAN HAIGH - Associated Press

In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Ted S. Warren, File)

Pfizer, BioNTech win FDA fast-track approval for two coronavirus vaccine candidates

By David Sherfinski - The Washington Times